Averin Capital LLC
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- HQ
- MA
Averin Capital is an early-stage venture firm that invests in AI and breakthrough technologies transforming human health. The firm focuses on ambitious founders and brings domain expertise and firsthand company-building experience. Its portfolio includes companies in wearable glucose sensing, primary care, cancer detection, robotics for procedures, musculoskeletal care, and mental health care. Dr. Mikael Dolsten has joined the firm as an advisor.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Healthtech, Digital health, Biotech, Medical devices, Robotics | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Averin Capital Fund II LP Averin Capital invests in breakthrough technologies transforming human health, including foundational science, physical AI, care delivery, healthcare infrastructure, and human performance. The firm backs ambitious founders with operator experience. Inferred from the firm's website | approx. 2026 | $350M (Form D) | Raising |
| Averin Capital Fund II-A LP Averin Capital invests in breakthrough technologies transforming human health, including foundational science, physical AI, care delivery, healthcare infrastructure, and human performance. The firm backs ambitious founders with operator experience. Inferred from the firm's website | approx. 2026 | $350M (Form D) | Raising |
03 · People across funds
- David Berry, Manager of the General Partner of the Issuer
Averin Capital Fund II LP (Named on Form D); Averin Capital Fund II-A LP (Named on Form D)
- Eric Berry, Managing Partner
Averin Capital Fund II LP (Named on Form D); Averin Capital Fund II-A LP (Named on Form D)
- Alex Lau, Partner & Chief Operating Officer
Averin Capital Fund II LP (Team); Averin Capital Fund II-A LP (Team)
- Amy Therattil, Chief of Staff
Averin Capital Fund II LP (Team); Averin Capital Fund II-A LP (Team)
- Ben Tomaszewski, Investor
Averin Capital Fund II LP (Team); Averin Capital Fund II-A LP (Team)
- David Berry, MD PhD, Managing Partner
Averin Capital Fund II LP (Team); Averin Capital Fund II-A LP (Team)
- Oanh Sam, Director, Operations & Experience
Averin Capital Fund II LP (Team); Averin Capital Fund II-A LP (Team)
- Tristan Hunt, MD, Partner
Averin Capital Fund II LP (Team); Averin Capital Fund II-A LP (Team)
- Jeffrey Low, MD, Partner
On the team page, not linked to a fund
- Tomer Zitelny, Partner
On the team page, not linked to a fund
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
- Team changeWelcoming Dr. Mikael Dolsten to the Averin Advisory BoardJun 30, 2026
06 · Sources
- https://www.averincapital.com/
- https://www.averincapital.com/companies
- https://www.averincapital.com/team
- https://www.averincapital.com/insights/welcoming-dr-mikael-dolsten-to-the-averin-advisory-board
- https://www.averincapital.com/team/david-berry
- https://www.averincapital.com/team/tristan-hunt
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026